nodes	percent_of_prediction	percent_of_DWPC	metapath
Pimozide—CYP2E1—liver cancer	0.434	1	CbGaD
Pimozide—CYP3A7-CYP3A51P—Sorafenib—liver cancer	0.055	0.169	CbGbCtD
Pimozide—CYP3A7—Sorafenib—liver cancer	0.055	0.169	CbGbCtD
Pimozide—CYP3A5—Sorafenib—liver cancer	0.0412	0.127	CbGbCtD
Pimozide—CYP2C19—Sorafenib—liver cancer	0.0333	0.102	CbGbCtD
Pimozide—CYP1A2—Sorafenib—liver cancer	0.0307	0.0945	CbGbCtD
Pimozide—ABCB1—Sorafenib—liver cancer	0.0268	0.0826	CbGbCtD
Pimozide—CYP2D6—Sorafenib—liver cancer	0.0253	0.0779	CbGbCtD
Pimozide—ABCB1—Doxorubicin—liver cancer	0.0163	0.0501	CbGbCtD
Pimozide—CYP3A4—Sorafenib—liver cancer	0.0161	0.0495	CbGbCtD
Pimozide—CYP2D6—Doxorubicin—liver cancer	0.0153	0.0473	CbGbCtD
Pimozide—CYP3A4—Doxorubicin—liver cancer	0.00975	0.03	CbGbCtD
Pimozide—Endocrine disorder—Sorafenib—liver cancer	0.00167	0.0295	CcSEcCtD
Pimozide—Gynaecomastia—Sorafenib—liver cancer	0.00124	0.0219	CcSEcCtD
Pimozide—Hyponatraemia—Sorafenib—liver cancer	0.00101	0.0178	CcSEcCtD
Pimozide—Hypothermia—Epirubicin—liver cancer	0.000913	0.0161	CcSEcCtD
Pimozide—Body temperature decreased—Epirubicin—liver cancer	0.000913	0.0161	CcSEcCtD
Pimozide—Breast disorder—Sorafenib—liver cancer	0.000909	0.016	CcSEcCtD
Pimozide—Dysphagia—Sorafenib—liver cancer	0.000869	0.0153	CcSEcCtD
Pimozide—Hypothermia—Doxorubicin—liver cancer	0.000845	0.0149	CcSEcCtD
Pimozide—Body temperature decreased—Doxorubicin—liver cancer	0.000845	0.0149	CcSEcCtD
Pimozide—Abdominal discomfort—Sorafenib—liver cancer	0.000833	0.0147	CcSEcCtD
Pimozide—Erectile dysfunction—Sorafenib—liver cancer	0.000801	0.0141	CcSEcCtD
Pimozide—Weight decreased—Sorafenib—liver cancer	0.000786	0.0139	CcSEcCtD
Pimozide—Connective tissue disorder—Sorafenib—liver cancer	0.000684	0.0121	CcSEcCtD
Pimozide—Cardiac disorder—Sorafenib—liver cancer	0.000646	0.0114	CcSEcCtD
Pimozide—Blood disorder—Epirubicin—liver cancer	0.000613	0.0108	CcSEcCtD
Pimozide—Mental disorder—Sorafenib—liver cancer	0.00061	0.0107	CcSEcCtD
Pimozide—Amenorrhoea—Epirubicin—liver cancer	0.000583	0.0103	CcSEcCtD
Pimozide—Muscle spasms—Sorafenib—liver cancer	0.000582	0.0103	CcSEcCtD
Pimozide—Blood disorder—Doxorubicin—liver cancer	0.000567	0.01	CcSEcCtD
Pimozide—Anaemia—Sorafenib—liver cancer	0.00056	0.00987	CcSEcCtD
Pimozide—Nocturia—Epirubicin—liver cancer	0.000552	0.00973	CcSEcCtD
Pimozide—Dyskinesia—Epirubicin—liver cancer	0.000545	0.00961	CcSEcCtD
Pimozide—Syncope—Sorafenib—liver cancer	0.000543	0.00958	CcSEcCtD
Pimozide—Leukopenia—Sorafenib—liver cancer	0.000542	0.00956	CcSEcCtD
Pimozide—Amenorrhoea—Doxorubicin—liver cancer	0.000539	0.00951	CcSEcCtD
Pimozide—Loss of consciousness—Sorafenib—liver cancer	0.000532	0.00939	CcSEcCtD
Pimozide—Hypertension—Sorafenib—liver cancer	0.000523	0.00922	CcSEcCtD
Pimozide—Myalgia—Sorafenib—liver cancer	0.000516	0.00909	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.000512	0.00903	CcSEcCtD
Pimozide—Ventricular tachycardia—Epirubicin—liver cancer	0.000512	0.00903	CcSEcCtD
Pimozide—Nocturia—Doxorubicin—liver cancer	0.000511	0.009	CcSEcCtD
Pimozide—Abnormal dreams—Epirubicin—liver cancer	0.000506	0.00892	CcSEcCtD
Pimozide—Dry mouth—Sorafenib—liver cancer	0.000504	0.00889	CcSEcCtD
Pimozide—Dyskinesia—Doxorubicin—liver cancer	0.000504	0.00889	CcSEcCtD
Pimozide—Eructation—Epirubicin—liver cancer	0.000503	0.00887	CcSEcCtD
Pimozide—Salivary hypersecretion—Epirubicin—liver cancer	0.000497	0.00877	CcSEcCtD
Pimozide—Shock—Sorafenib—liver cancer	0.000486	0.00857	CcSEcCtD
Pimozide—Nervous system disorder—Sorafenib—liver cancer	0.000485	0.00855	CcSEcCtD
Pimozide—Aplastic anaemia—Epirubicin—liver cancer	0.000481	0.00848	CcSEcCtD
Pimozide—Skin disorder—Sorafenib—liver cancer	0.00048	0.00847	CcSEcCtD
Pimozide—Ventricular tachycardia—Doxorubicin—liver cancer	0.000474	0.00835	CcSEcCtD
Pimozide—Anorexia—Sorafenib—liver cancer	0.000471	0.00831	CcSEcCtD
Pimozide—Abnormal dreams—Doxorubicin—liver cancer	0.000468	0.00825	CcSEcCtD
Pimozide—Eructation—Doxorubicin—liver cancer	0.000465	0.00821	CcSEcCtD
Pimozide—Salivary hypersecretion—Doxorubicin—liver cancer	0.00046	0.00811	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00045	0.00794	CcSEcCtD
Pimozide—Aplastic anaemia—Doxorubicin—liver cancer	0.000445	0.00784	CcSEcCtD
Pimozide—Decreased appetite—Sorafenib—liver cancer	0.00043	0.00758	CcSEcCtD
Pimozide—Gastrointestinal disorder—Sorafenib—liver cancer	0.000427	0.00752	CcSEcCtD
Pimozide—Constipation—Sorafenib—liver cancer	0.000423	0.00745	CcSEcCtD
Pimozide—Increased appetite—Epirubicin—liver cancer	0.000396	0.00697	CcSEcCtD
Pimozide—Urticaria—Sorafenib—liver cancer	0.000393	0.00692	CcSEcCtD
Pimozide—Hyponatraemia—Epirubicin—liver cancer	0.000373	0.00658	CcSEcCtD
Pimozide—Increased appetite—Doxorubicin—liver cancer	0.000366	0.00645	CcSEcCtD
Pimozide—Asthenia—Sorafenib—liver cancer	0.000355	0.00625	CcSEcCtD
Pimozide—Pruritus—Sorafenib—liver cancer	0.00035	0.00617	CcSEcCtD
Pimozide—Hyponatraemia—Doxorubicin—liver cancer	0.000345	0.00609	CcSEcCtD
Pimozide—Orthostatic hypotension—Epirubicin—liver cancer	0.000339	0.00599	CcSEcCtD
Pimozide—Diarrhoea—Sorafenib—liver cancer	0.000338	0.00596	CcSEcCtD
Pimozide—Breast disorder—Epirubicin—liver cancer	0.000336	0.00592	CcSEcCtD
Pimozide—Dizziness—Sorafenib—liver cancer	0.000327	0.00576	CcSEcCtD
Pimozide—Dysphagia—Epirubicin—liver cancer	0.000321	0.00566	CcSEcCtD
Pimozide—Eosinophilia—Epirubicin—liver cancer	0.000318	0.00561	CcSEcCtD
Pimozide—Vomiting—Sorafenib—liver cancer	0.000314	0.00554	CcSEcCtD
Pimozide—Orthostatic hypotension—Doxorubicin—liver cancer	0.000314	0.00554	CcSEcCtD
Pimozide—Rash—Sorafenib—liver cancer	0.000312	0.00549	CcSEcCtD
Pimozide—Dermatitis—Sorafenib—liver cancer	0.000311	0.00549	CcSEcCtD
Pimozide—Breast disorder—Doxorubicin—liver cancer	0.000311	0.00548	CcSEcCtD
Pimozide—Headache—Sorafenib—liver cancer	0.00031	0.00546	CcSEcCtD
Pimozide—Pancytopenia—Epirubicin—liver cancer	0.000305	0.00538	CcSEcCtD
Pimozide—Dysphagia—Doxorubicin—liver cancer	0.000297	0.00524	CcSEcCtD
Pimozide—Pollakiuria—Epirubicin—liver cancer	0.000297	0.00523	CcSEcCtD
Pimozide—Eosinophilia—Doxorubicin—liver cancer	0.000294	0.00519	CcSEcCtD
Pimozide—Nausea—Sorafenib—liver cancer	0.000294	0.00518	CcSEcCtD
Pimozide—Weight increased—Epirubicin—liver cancer	0.000292	0.00515	CcSEcCtD
Pimozide—Weight decreased—Epirubicin—liver cancer	0.000291	0.00512	CcSEcCtD
Pimozide—Drowsiness—Epirubicin—liver cancer	0.000286	0.00505	CcSEcCtD
Pimozide—Pancytopenia—Doxorubicin—liver cancer	0.000282	0.00498	CcSEcCtD
Pimozide—Sweating—Epirubicin—liver cancer	0.000275	0.00484	CcSEcCtD
Pimozide—Pollakiuria—Doxorubicin—liver cancer	0.000275	0.00484	CcSEcCtD
Pimozide—Weight increased—Doxorubicin—liver cancer	0.000271	0.00477	CcSEcCtD
Pimozide—Weight decreased—Doxorubicin—liver cancer	0.000269	0.00474	CcSEcCtD
Pimozide—Agranulocytosis—Epirubicin—liver cancer	0.000267	0.00471	CcSEcCtD
Pimozide—Drowsiness—Doxorubicin—liver cancer	0.000265	0.00467	CcSEcCtD
Pimozide—Sweating—Doxorubicin—liver cancer	0.000254	0.00448	CcSEcCtD
Pimozide—Connective tissue disorder—Epirubicin—liver cancer	0.000253	0.00445	CcSEcCtD
Pimozide—Visual impairment—Epirubicin—liver cancer	0.000248	0.00437	CcSEcCtD
Pimozide—Agranulocytosis—Doxorubicin—liver cancer	0.000247	0.00436	CcSEcCtD
Pimozide—Eye disorder—Epirubicin—liver cancer	0.00024	0.00424	CcSEcCtD
Pimozide—Cardiac disorder—Epirubicin—liver cancer	0.000239	0.00421	CcSEcCtD
Pimozide—Connective tissue disorder—Doxorubicin—liver cancer	0.000234	0.00412	CcSEcCtD
Pimozide—Visual impairment—Doxorubicin—liver cancer	0.000229	0.00404	CcSEcCtD
Pimozide—Mental disorder—Epirubicin—liver cancer	0.000225	0.00397	CcSEcCtD
Pimozide—Eye disorder—Doxorubicin—liver cancer	0.000222	0.00392	CcSEcCtD
Pimozide—Cardiac disorder—Doxorubicin—liver cancer	0.000221	0.00389	CcSEcCtD
Pimozide—Muscle spasms—Epirubicin—liver cancer	0.000215	0.00379	CcSEcCtD
Pimozide—Vision blurred—Epirubicin—liver cancer	0.000211	0.00372	CcSEcCtD
Pimozide—Mental disorder—Doxorubicin—liver cancer	0.000208	0.00367	CcSEcCtD
Pimozide—Anaemia—Epirubicin—liver cancer	0.000207	0.00365	CcSEcCtD
Pimozide—Agitation—Epirubicin—liver cancer	0.000206	0.00363	CcSEcCtD
Pimozide—Syncope—Epirubicin—liver cancer	0.000201	0.00354	CcSEcCtD
Pimozide—Leukopenia—Epirubicin—liver cancer	0.0002	0.00353	CcSEcCtD
Pimozide—Muscle spasms—Doxorubicin—liver cancer	0.000199	0.00351	CcSEcCtD
Pimozide—Palpitations—Epirubicin—liver cancer	0.000198	0.00349	CcSEcCtD
Pimozide—Loss of consciousness—Epirubicin—liver cancer	0.000197	0.00347	CcSEcCtD
Pimozide—Vision blurred—Doxorubicin—liver cancer	0.000195	0.00344	CcSEcCtD
Pimozide—Convulsion—Epirubicin—liver cancer	0.000194	0.00342	CcSEcCtD
Pimozide—Hypertension—Epirubicin—liver cancer	0.000193	0.00341	CcSEcCtD
Pimozide—Anaemia—Doxorubicin—liver cancer	0.000191	0.00337	CcSEcCtD
Pimozide—Chest pain—Epirubicin—liver cancer	0.000191	0.00336	CcSEcCtD
Pimozide—Myalgia—Epirubicin—liver cancer	0.000191	0.00336	CcSEcCtD
Pimozide—Agitation—Doxorubicin—liver cancer	0.00019	0.00336	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000189	0.00334	CcSEcCtD
Pimozide—Dry mouth—Epirubicin—liver cancer	0.000186	0.00329	CcSEcCtD
Pimozide—Syncope—Doxorubicin—liver cancer	0.000186	0.00327	CcSEcCtD
Pimozide—Leukopenia—Doxorubicin—liver cancer	0.000185	0.00327	CcSEcCtD
Pimozide—Palpitations—Doxorubicin—liver cancer	0.000183	0.00323	CcSEcCtD
Pimozide—Loss of consciousness—Doxorubicin—liver cancer	0.000182	0.00321	CcSEcCtD
Pimozide—Shock—Epirubicin—liver cancer	0.00018	0.00317	CcSEcCtD
Pimozide—Convulsion—Doxorubicin—liver cancer	0.000179	0.00316	CcSEcCtD
Pimozide—Nervous system disorder—Epirubicin—liver cancer	0.000179	0.00316	CcSEcCtD
Pimozide—Hypertension—Doxorubicin—liver cancer	0.000179	0.00315	CcSEcCtD
Pimozide—Tachycardia—Epirubicin—liver cancer	0.000178	0.00314	CcSEcCtD
Pimozide—Skin disorder—Epirubicin—liver cancer	0.000177	0.00313	CcSEcCtD
Pimozide—Hyperhidrosis—Epirubicin—liver cancer	0.000177	0.00311	CcSEcCtD
Pimozide—Myalgia—Doxorubicin—liver cancer	0.000176	0.00311	CcSEcCtD
Pimozide—Chest pain—Doxorubicin—liver cancer	0.000176	0.00311	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000175	0.00309	CcSEcCtD
Pimozide—Anorexia—Epirubicin—liver cancer	0.000174	0.00307	CcSEcCtD
Pimozide—Dry mouth—Doxorubicin—liver cancer	0.000172	0.00304	CcSEcCtD
Pimozide—Hypotension—Epirubicin—liver cancer	0.000171	0.00301	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000166	0.00293	CcSEcCtD
Pimozide—Shock—Doxorubicin—liver cancer	0.000166	0.00293	CcSEcCtD
Pimozide—Nervous system disorder—Doxorubicin—liver cancer	0.000166	0.00292	CcSEcCtD
Pimozide—Insomnia—Epirubicin—liver cancer	0.000165	0.00291	CcSEcCtD
Pimozide—Tachycardia—Doxorubicin—liver cancer	0.000165	0.00291	CcSEcCtD
Pimozide—Skin disorder—Doxorubicin—liver cancer	0.000164	0.00289	CcSEcCtD
Pimozide—Hyperhidrosis—Doxorubicin—liver cancer	0.000163	0.00288	CcSEcCtD
Pimozide—Somnolence—Epirubicin—liver cancer	0.000162	0.00286	CcSEcCtD
Pimozide—Anorexia—Doxorubicin—liver cancer	0.000161	0.00284	CcSEcCtD
Pimozide—Decreased appetite—Epirubicin—liver cancer	0.000159	0.0028	CcSEcCtD
Pimozide—Hypotension—Doxorubicin—liver cancer	0.000158	0.00278	CcSEcCtD
Pimozide—Gastrointestinal disorder—Epirubicin—liver cancer	0.000158	0.00278	CcSEcCtD
Pimozide—Constipation—Epirubicin—liver cancer	0.000156	0.00275	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000154	0.00272	CcSEcCtD
Pimozide—Insomnia—Doxorubicin—liver cancer	0.000153	0.0027	CcSEcCtD
Pimozide—Somnolence—Doxorubicin—liver cancer	0.00015	0.00265	CcSEcCtD
Pimozide—Decreased appetite—Doxorubicin—liver cancer	0.000147	0.00259	CcSEcCtD
Pimozide—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000146	0.00257	CcSEcCtD
Pimozide—Urticaria—Epirubicin—liver cancer	0.000145	0.00256	CcSEcCtD
Pimozide—Constipation—Doxorubicin—liver cancer	0.000145	0.00255	CcSEcCtD
Pimozide—Urticaria—Doxorubicin—liver cancer	0.000134	0.00237	CcSEcCtD
Pimozide—Asthenia—Epirubicin—liver cancer	0.000131	0.00231	CcSEcCtD
Pimozide—Pruritus—Epirubicin—liver cancer	0.000129	0.00228	CcSEcCtD
Pimozide—Diarrhoea—Epirubicin—liver cancer	0.000125	0.0022	CcSEcCtD
Pimozide—Asthenia—Doxorubicin—liver cancer	0.000121	0.00214	CcSEcCtD
Pimozide—Dizziness—Epirubicin—liver cancer	0.000121	0.00213	CcSEcCtD
Pimozide—Pruritus—Doxorubicin—liver cancer	0.00012	0.00211	CcSEcCtD
Pimozide—Vomiting—Epirubicin—liver cancer	0.000116	0.00205	CcSEcCtD
Pimozide—Diarrhoea—Doxorubicin—liver cancer	0.000116	0.00204	CcSEcCtD
Pimozide—Rash—Epirubicin—liver cancer	0.000115	0.00203	CcSEcCtD
Pimozide—Dermatitis—Epirubicin—liver cancer	0.000115	0.00203	CcSEcCtD
Pimozide—Headache—Epirubicin—liver cancer	0.000114	0.00202	CcSEcCtD
Pimozide—Dizziness—Doxorubicin—liver cancer	0.000112	0.00197	CcSEcCtD
Pimozide—Nausea—Epirubicin—liver cancer	0.000109	0.00191	CcSEcCtD
Pimozide—Vomiting—Doxorubicin—liver cancer	0.000107	0.00189	CcSEcCtD
Pimozide—Rash—Doxorubicin—liver cancer	0.000107	0.00188	CcSEcCtD
Pimozide—Dermatitis—Doxorubicin—liver cancer	0.000106	0.00188	CcSEcCtD
Pimozide—Headache—Doxorubicin—liver cancer	0.000106	0.00187	CcSEcCtD
Pimozide—Nausea—Doxorubicin—liver cancer	0.0001	0.00177	CcSEcCtD
Pimozide—OPRM1—Signaling Pathways—KRAS—liver cancer	4.87e-06	2.63e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—CTNNB1—liver cancer	4.85e-06	2.62e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—GSTP1—liver cancer	4.85e-06	2.62e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—STAT3—liver cancer	4.85e-06	2.62e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—STAT3—liver cancer	4.85e-06	2.62e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—CTNNB1—liver cancer	4.84e-06	2.62e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—PIK3CD—liver cancer	4.84e-06	2.62e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—MMP9—liver cancer	4.83e-06	2.61e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—HRAS—liver cancer	4.82e-06	2.61e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—KRAS—liver cancer	4.82e-06	2.61e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—CDKN1A—liver cancer	4.81e-06	2.6e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—CCND1—liver cancer	4.81e-06	2.6e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—JUN—liver cancer	4.8e-06	2.6e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—HMOX1—liver cancer	4.78e-06	2.59e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—ALB—liver cancer	4.77e-06	2.58e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—CTNNB1—liver cancer	4.76e-06	2.58e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—MMP9—liver cancer	4.75e-06	2.57e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—MMP9—liver cancer	4.74e-06	2.57e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—CDKN1A—liver cancer	4.74e-06	2.56e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—CDKN1A—liver cancer	4.73e-06	2.56e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—PIK3CD—liver cancer	4.72e-06	2.55e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—MAPK8—liver cancer	4.7e-06	2.54e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling by GPCR—AKT1—liver cancer	4.68e-06	2.53e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—PIK3CA—liver cancer	4.68e-06	2.53e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—IL6—liver cancer	4.68e-06	2.53e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—MMP9—liver cancer	4.67e-06	2.52e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—ALB—liver cancer	4.66e-06	2.52e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—KRAS—liver cancer	4.66e-06	2.52e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—MYC—liver cancer	4.65e-06	2.52e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—CDKN1A—liver cancer	4.65e-06	2.52e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—RAF1—liver cancer	4.65e-06	2.52e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—TGFB1—liver cancer	4.64e-06	2.51e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—MAPK8—liver cancer	4.62e-06	2.5e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—IL6—liver cancer	4.62e-06	2.5e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—MAPK8—liver cancer	4.61e-06	2.5e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling by GPCR—AKT1—liver cancer	4.61e-06	2.49e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling by GPCR—AKT1—liver cancer	4.6e-06	2.49e-05	CbGpPWpGaD
Pimozide—CYP3A7—Metabolism—PIK3CA—liver cancer	4.6e-06	2.49e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—MYC—liver cancer	4.55e-06	2.46e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—PIK3CB—liver cancer	4.54e-06	2.46e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—MTOR—liver cancer	4.54e-06	2.46e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—MAPK8—liver cancer	4.54e-06	2.46e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—TGFB1—liver cancer	4.53e-06	2.45e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—PIK3CA—liver cancer	4.53e-06	2.45e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—PIK3CA—liver cancer	4.53e-06	2.45e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling by GPCR—AKT1—liver cancer	4.53e-06	2.45e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—KRAS—liver cancer	4.51e-06	2.44e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—KRAS—liver cancer	4.51e-06	2.44e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—MYC—liver cancer	4.5e-06	2.44e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—MYC—liver cancer	4.5e-06	2.44e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—RAF1—liver cancer	4.5e-06	2.43e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—RAF1—liver cancer	4.5e-06	2.43e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	4.5e-06	2.43e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—TGFB1—liver cancer	4.49e-06	2.43e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—TGFB1—liver cancer	4.49e-06	2.43e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—PIK3CA—liver cancer	4.47e-06	2.42e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—GSTM1—liver cancer	4.45e-06	2.41e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—PIK3CD—liver cancer	4.45e-06	2.41e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—PIK3CA—liver cancer	4.43e-06	2.4e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—PIK3CB—liver cancer	4.39e-06	2.38e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—PIK3CB—liver cancer	4.39e-06	2.38e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—MTOR—liver cancer	4.39e-06	2.38e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—MTOR—liver cancer	4.39e-06	2.38e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—ALB—liver cancer	4.39e-06	2.38e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—VEGFA—liver cancer	4.34e-06	2.35e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—HRAS—liver cancer	4.33e-06	2.34e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—TP53—liver cancer	4.32e-06	2.34e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—AKT1—liver cancer	4.32e-06	2.34e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—KRAS—liver cancer	4.3e-06	2.33e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—STAT3—liver cancer	4.29e-06	2.32e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—PIK3CG—liver cancer	4.29e-06	2.32e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—TP53—liver cancer	4.28e-06	2.32e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—PIK3CA—liver cancer	4.28e-06	2.32e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—VEGFA—liver cancer	4.27e-06	2.31e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—CDKN1B—liver cancer	4.26e-06	2.3e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—VEGFA—liver cancer	4.26e-06	2.3e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—AKT1—liver cancer	4.26e-06	2.3e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—STAT3—liver cancer	4.23e-06	2.29e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—CYP1A1—liver cancer	4.22e-06	2.29e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—STAT3—liver cancer	4.22e-06	2.28e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—PIK3CB—liver cancer	4.22e-06	2.28e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—KRAS—liver cancer	4.2e-06	2.27e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—HRAS—liver cancer	4.19e-06	2.27e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—HRAS—liver cancer	4.19e-06	2.27e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—VEGFA—liver cancer	4.19e-06	2.27e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—CASP3—liver cancer	4.17e-06	2.26e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—IL2—liver cancer	4.17e-06	2.26e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—KRAS—liver cancer	4.16e-06	2.25e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—KRAS—liver cancer	4.16e-06	2.25e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—STAT3—liver cancer	4.15e-06	2.25e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—IL6—liver cancer	4.15e-06	2.24e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—PIK3CA—liver cancer	4.14e-06	2.24e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—PIK3CA—liver cancer	4.14e-06	2.24e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—PPARG—liver cancer	4.14e-06	2.24e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—HRAS—liver cancer	4.14e-06	2.24e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—CDKN1B—liver cancer	4.12e-06	2.23e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—CDKN1B—liver cancer	4.12e-06	2.23e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—PIK3CB—liver cancer	4.11e-06	2.23e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—HRAS—liver cancer	4.1e-06	2.22e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—CCND1—liver cancer	4.06e-06	2.2e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—JUN—liver cancer	4.06e-06	2.19e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—CASP3—liver cancer	4.04e-06	2.19e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—CASP3—liver cancer	4.04e-06	2.19e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—IL2—liver cancer	4.03e-06	2.18e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—IL2—liver cancer	4.03e-06	2.18e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—CTNNB1—liver cancer	4.02e-06	2.18e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—IL6—liver cancer	4.01e-06	2.17e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—IL6—liver cancer	4.01e-06	2.17e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—MYC—liver cancer	3.99e-06	2.16e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—TGFB1—liver cancer	3.98e-06	2.15e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—HRAS—liver cancer	3.96e-06	2.14e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—IL6—liver cancer	3.96e-06	2.14e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—PIK3CA—liver cancer	3.95e-06	2.14e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—MMP9—liver cancer	3.95e-06	2.13e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—MTHFR—liver cancer	3.94e-06	2.13e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—CDKN1A—liver cancer	3.93e-06	2.13e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—CCND1—liver cancer	3.93e-06	2.13e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—CCND1—liver cancer	3.93e-06	2.13e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—MYC—liver cancer	3.93e-06	2.12e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—JUN—liver cancer	3.92e-06	2.12e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—JUN—liver cancer	3.92e-06	2.12e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—IL6—liver cancer	3.92e-06	2.12e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—MYC—liver cancer	3.92e-06	2.12e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—TGFB1—liver cancer	3.92e-06	2.12e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—TGFB1—liver cancer	3.91e-06	2.11e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—CTNNB1—liver cancer	3.89e-06	2.11e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—CTNNB1—liver cancer	3.89e-06	2.11e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—PIK3CB—liver cancer	3.88e-06	2.1e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—PPARA—liver cancer	3.86e-06	2.09e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—PIK3CA—liver cancer	3.86e-06	2.09e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—MYC—liver cancer	3.86e-06	2.09e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—TGFB1—liver cancer	3.85e-06	2.08e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—MAPK8—liver cancer	3.84e-06	2.08e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—HRAS—liver cancer	3.83e-06	2.07e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—HRAS—liver cancer	3.83e-06	2.07e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—AKT1—liver cancer	3.83e-06	2.07e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—PIK3CA—liver cancer	3.82e-06	2.07e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—PIK3CA—liver cancer	3.82e-06	2.07e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—MMP9—liver cancer	3.82e-06	2.07e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—MMP9—liver cancer	3.82e-06	2.07e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—CDKN1A—liver cancer	3.8e-06	2.06e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—CDKN1A—liver cancer	3.8e-06	2.06e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—IL6—liver cancer	3.79e-06	2.05e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—PIK3CD—liver cancer	3.77e-06	2.04e-05	CbGpPWpGaD
Pimozide—CYP3A7—Metabolism—AKT1—liver cancer	3.76e-06	2.03e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—TP53—liver cancer	3.73e-06	2.02e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—ALB—liver cancer	3.72e-06	2.01e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—MAPK8—liver cancer	3.71e-06	2.01e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—MAPK8—liver cancer	3.71e-06	2.01e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—AKT1—liver cancer	3.7e-06	2e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—AKT1—liver cancer	3.7e-06	2e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—KRAS—liver cancer	3.69e-06	2e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—IL6—liver cancer	3.67e-06	1.98e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—IL6—liver cancer	3.67e-06	1.98e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—HRAS—liver cancer	3.66e-06	1.98e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—AKT1—liver cancer	3.65e-06	1.98e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—KRAS—liver cancer	3.63e-06	1.96e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—KRAS—liver cancer	3.62e-06	1.96e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—AKT1—liver cancer	3.62e-06	1.96e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—HRAS—liver cancer	3.57e-06	1.93e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—KRAS—liver cancer	3.56e-06	1.93e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—VEGFA—liver cancer	3.54e-06	1.92e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—HRAS—liver cancer	3.54e-06	1.91e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—HRAS—liver cancer	3.54e-06	1.91e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—STAT3—liver cancer	3.51e-06	1.9e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—IL6—liver cancer	3.5e-06	1.89e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—AKT1—liver cancer	3.5e-06	1.89e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—VEGFA—liver cancer	3.43e-06	1.85e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—VEGFA—liver cancer	3.43e-06	1.85e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—IL6—liver cancer	3.42e-06	1.85e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—STAT3—liver cancer	3.39e-06	1.84e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—STAT3—liver cancer	3.39e-06	1.84e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—PIK3CA—liver cancer	3.39e-06	1.83e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—IL6—liver cancer	3.38e-06	1.83e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—IL6—liver cancer	3.38e-06	1.83e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—AKT1—liver cancer	3.38e-06	1.83e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—AKT1—liver cancer	3.38e-06	1.83e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—PIK3CA—liver cancer	3.33e-06	1.8e-05	CbGpPWpGaD
Pimozide—CYP2E1—Metabolism—PIK3CA—liver cancer	3.33e-06	1.8e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—PIK3CA—liver cancer	3.33e-06	1.8e-05	CbGpPWpGaD
Pimozide—CYP3A5—Metabolism—PIK3CA—liver cancer	3.32e-06	1.8e-05	CbGpPWpGaD
Pimozide—CALM3—Metabolism—PIK3CA—liver cancer	3.31e-06	1.79e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—PIK3CG—liver cancer	3.31e-06	1.79e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—PIK3CB—liver cancer	3.28e-06	1.78e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—TP53—liver cancer	3.28e-06	1.77e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—PIK3CA—liver cancer	3.27e-06	1.77e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—MYC—liver cancer	3.26e-06	1.76e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—TGFB1—liver cancer	3.25e-06	1.76e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—AKT1—liver cancer	3.23e-06	1.75e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—TP53—liver cancer	3.22e-06	1.74e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—TP53—liver cancer	3.22e-06	1.74e-05	CbGpPWpGaD
Pimozide—CALM2—Metabolism—PIK3CA—liver cancer	3.2e-06	1.73e-05	CbGpPWpGaD
Pimozide—CALM1—Metabolism—PIK3CA—liver cancer	3.2e-06	1.73e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—PPARG—liver cancer	3.19e-06	1.73e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—TP53—liver cancer	3.17e-06	1.71e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—MYC—liver cancer	3.15e-06	1.71e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—MYC—liver cancer	3.15e-06	1.71e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—AKT1—liver cancer	3.15e-06	1.71e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—TGFB1—liver cancer	3.15e-06	1.7e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—TGFB1—liver cancer	3.15e-06	1.7e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—HRAS—liver cancer	3.13e-06	1.7e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—AKT1—liver cancer	3.12e-06	1.69e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—AKT1—liver cancer	3.12e-06	1.69e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—HRAS—liver cancer	3.08e-06	1.67e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—HRAS—liver cancer	3.08e-06	1.67e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—HRAS—liver cancer	3.03e-06	1.64e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—KRAS—liver cancer	3.01e-06	1.63e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—IL6—liver cancer	3e-06	1.62e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—IL6—liver cancer	2.95e-06	1.6e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—IL6—liver cancer	2.95e-06	1.59e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—KRAS—liver cancer	2.91e-06	1.58e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—KRAS—liver cancer	2.91e-06	1.58e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—PIK3CD—liver cancer	2.91e-06	1.57e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—IL6—liver cancer	2.9e-06	1.57e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—ALB—liver cancer	2.87e-06	1.55e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—AKT1—liver cancer	2.77e-06	1.5e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—PIK3CA—liver cancer	2.77e-06	1.5e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—AKT1—liver cancer	2.72e-06	1.47e-05	CbGpPWpGaD
Pimozide—CYP2E1—Metabolism—AKT1—liver cancer	2.72e-06	1.47e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—AKT1—liver cancer	2.72e-06	1.47e-05	CbGpPWpGaD
Pimozide—CYP3A5—Metabolism—AKT1—liver cancer	2.72e-06	1.47e-05	CbGpPWpGaD
Pimozide—CALM3—Metabolism—AKT1—liver cancer	2.7e-06	1.46e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—TP53—liver cancer	2.68e-06	1.45e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—PIK3CA—liver cancer	2.68e-06	1.45e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—PIK3CA—liver cancer	2.68e-06	1.45e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—AKT1—liver cancer	2.67e-06	1.45e-05	CbGpPWpGaD
Pimozide—CALM1—Metabolism—AKT1—liver cancer	2.62e-06	1.41e-05	CbGpPWpGaD
Pimozide—CALM2—Metabolism—AKT1—liver cancer	2.62e-06	1.41e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—TP53—liver cancer	2.59e-06	1.4e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—TP53—liver cancer	2.59e-06	1.4e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—PIK3CA—liver cancer	2.57e-06	1.39e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—HRAS—liver cancer	2.56e-06	1.39e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—PIK3CB—liver cancer	2.53e-06	1.37e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—PIK3CA—liver cancer	2.51e-06	1.36e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—HRAS—liver cancer	2.48e-06	1.34e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—HRAS—liver cancer	2.48e-06	1.34e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—IL6—liver cancer	2.45e-06	1.33e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—IL6—liver cancer	2.37e-06	1.28e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—IL6—liver cancer	2.37e-06	1.28e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—PIK3CA—liver cancer	2.36e-06	1.28e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—AKT1—liver cancer	2.26e-06	1.22e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—AKT1—liver cancer	2.19e-06	1.18e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—AKT1—liver cancer	2.19e-06	1.18e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—AKT1—liver cancer	2.1e-06	1.14e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—AKT1—liver cancer	2.05e-06	1.11e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—PIK3CA—liver cancer	2e-06	1.08e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—AKT1—liver cancer	1.93e-06	1.04e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—AKT1—liver cancer	1.64e-06	8.85e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—PIK3CA—liver cancer	1.55e-06	8.36e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—AKT1—liver cancer	1.26e-06	6.83e-06	CbGpPWpGaD
